Quick Answer
Microbot Medical Inc. reported Diluted EPS of $0.29 per share (loss) for fiscal year 2025.
Microbot Medical Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.29 | +60.3% |
| 2024 | -$0.73 | +30.5% |
| 2023 | -$1.05 | +42.0% |
| 2022 | -$1.81 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.07 | +65.0% | +30.0% |
| June 30, 2025 | -$0.10 | +41.2% | -25.0% |
| March 31, 2025 | -$0.08 | +52.9% | +60.0% |
| September 30, 2024 | -$0.20 | +4.8% | -17.6% |
| June 30, 2024 | -$0.17 | +32.0% | +0.0% |
| March 31, 2024 | -$0.17 | +52.8% | +19.0% |
| September 30, 2023 | -$0.21 | +57.1% | +16.0% |
| June 30, 2023 | -$0.25 | +49.0% | +30.6% |
- Microbot Medical Inc. showed an increase of +60.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, Microbot Medical Inc.’s diluted eps has grown by 84.0% (from $1.81 per share (loss) to $0.29 per share (loss)).
- The most recent figure is from Microbot Medical Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: